A number of pathogenic microorganisms, including, several NIAID Priority Pathogens, secrete virulence factors utilizing a novel pathway referred to as the type VI secretion system (T6SS). The main objective of this project is to develop inhibitors of T6SS that could lead to a new class of antimicrobial agents. Burkholderia thailandensis will be used to identify T6SS inhibitors compounds in a high throughput screen and these will be tested for interference with secretion in several category A-C select agents, including Burkholderia pseudomallei and Burkholderia mallei, causative agents of melioidosis and glanders, respectively. The candidate inhibitors of T6SS and their structural derivatives will be used in subsequent studies, which include demonstration of their efficacy in an animal model of melioidosis. The T6SS components, targeted by the active compounds will be identified. The work proposed in this project represents a logical pre-clinical development strategy for therapeutic agents targeting several agents of biological warfare and bioterrorism.

Public Health Relevance

The project is aimed at the identification of inhibitors a shared virulence mechanism in two NIAID Priority Pathogens, Burkholderia pseudomallei and Burkholderia mallei. The lack of a vaccines and the high mortality associated with B. pseudomallei and B. mallei infections, despite antibiotic treatment, enhances their utility as agents of biological warfare and bioterrorism. The proposed project is directed towards the development of novel anti-microbial agents and therefore it is a good fit with the main objectives of NERCE which seeks to promote the development of vaccines and therapeutics against select agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54AI057159-07
Application #
8038355
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-03-01
Budget End
2011-02-28
Support Year
7
Fiscal Year
2010
Total Cost
$353,385
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
de Wispelaere, Melissanne; Lian, Wenlong; Potisopon, Supanee et al. (2018) Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein. Cell Chem Biol 25:1006-1016.e8
Huang, Nai-Jia; Pishesha, Novalia; Mukherjee, Jean et al. (2017) Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin. Nat Commun 8:423
Mertins, Philipp; Przybylski, Dariusz; Yosef, Nir et al. (2017) An Integrative Framework Reveals Signaling-to-Transcription Events in Toll-like Receptor Signaling. Cell Rep 19:2853-2866
Nair, Dhanalakshmi R; Chen, Ji; Monteiro, João M et al. (2017) A quinolinol-based small molecule with anti-MRSA activity that targets bacterial membrane and promotes fermentative metabolism. J Antibiot (Tokyo) 70:1009-1019
Choo, Min-Kyung; Sano, Yasuyo; Kim, Changhoon et al. (2017) TLR sensing of bacterial spore-associated RNA triggers host immune responses with detrimental effects. J Exp Med 214:1297-1311
de Wispelaere, Mélissanne; Carocci, Margot; Liang, Yanke et al. (2017) Discovery of host-targeted covalent inhibitors of dengue virus. Antiviral Res 139:171-179
Umetsu, Dale T (2017) Mechanisms by which obesity impacts upon asthma. Thorax 72:174-177
Zheng, Huiqing; Colvin, Christopher J; Johnson, Benjamin K et al. (2017) Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence. Nat Chem Biol 13:218-225
Coulson, Garry B; Johnson, Benjamin K; Zheng, Huiqing et al. (2017) Targeting Mycobacterium tuberculosis Sensitivity to Thiol Stress at Acidic pH Kills the Bacterium and Potentiates Antibiotics. Cell Chem Biol 24:993-1004.e4
Taylor, Travis J; Diaz, Fernando; Colgrove, Robert C et al. (2016) Production of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vector. Virology 496:186-193

Showing the most recent 10 out of 417 publications